Literature DB >> 25452577

Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs.

Alan A Dombkowski1, Carlos E Batista1, Daniela Cukovic1, Nicholas J Carruthers2, Ramya Ranganathan1, Upasana Shukla1, Paul M Stemmer2, Harry T Chugani3, Diane C Chugani1.   

Abstract

Tuberous sclerosis complex (TSC) is a multisystem genetic disorder caused by mutations in the TSC1 and TSC2 genes. Over 80% of TSC patients are affected by epilepsy, but the molecular events contributing to seizures in TSC are not well understood. Recent reports have demonstrated that the brain is enriched with microRNA activity, and they are critical in neural development and function. However, little is known about the role of microRNAs in TSC. Here, we report the characterization of aberrant microRNA activity in cortical tubers resected from 5 TSC patients surgically treated for medically intractable epilepsy. By comparing epileptogenic tubers with adjacent nontuber tissue, we identified a set of 4 coordinately overexpressed microRNAs (miRs 23a, 34a, 34b*, 532-5p). We used quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) proteomic profiling to investigate the combined effect of the 4 microRNAs on target proteins. The proportion of repressed proteins among the predicted targets was significantly greater than in the overall proteome and was highly enriched for proteins involved in synaptic signal transmission. Among the combinatorial targets were TSC1, coding for the protein hamartin, and several epilepsy risk genes. We found decreased levels of hamartin in epileptogenic tubers and confirmed targeting of the TSC1 3' UTR by miRs-23a and 34a.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  expression profiling; hamartin; proteomics; synapse; tuberous sclerosis complex

Mesh:

Substances:

Year:  2014        PMID: 25452577      PMCID: PMC4737604          DOI: 10.1093/cercor/bhu276

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  80 in total

1.  A microRNA array reveals extensive regulation of microRNAs during brain development.

Authors:  Anna M Krichevsky; Kevin S King; Christine P Donahue; Konstantin Khrapko; Kenneth S Kosik
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

2.  Biallelic TSC gene inactivation in tuberous sclerosis complex.

Authors:  Peter B Crino; Eleonora Aronica; Gordon Baltuch; Katherine L Nathanson
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

Review 3.  Experimental validation of miRNA targets.

Authors:  Donald E Kuhn; Mickey M Martin; David S Feldman; Alvin V Terry; Gerard J Nuovo; Terry S Elton
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

4.  More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS.

Authors:  Annette Michalski; Juergen Cox; Matthias Mann
Journal:  J Proteome Res       Date:  2011-02-28       Impact factor: 4.466

Review 5.  Quantitative proteomic strategies for the identification of microRNA targets.

Authors:  Chongyang Li; Qian Xiong; Jia Zhang; Feng Ge; Li-Jun Bi
Journal:  Expert Rev Proteomics       Date:  2012-10       Impact factor: 3.940

6.  Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis.

Authors:  M Mizuguchi; M Kato; H Yamanouchi; K Ikeda; S Takashima
Journal:  Acta Neuropathol       Date:  1997-12       Impact factor: 17.088

7.  Epilepsy in individuals with neurofibromatosis type 1.

Authors:  Adam P Ostendorf; David H Gutmann; Judith L Z Weisenberg
Journal:  Epilepsia       Date:  2013-08-29       Impact factor: 5.864

8.  MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia.

Authors:  Chi-Yu Lai; Sung-Liang Yu; Ming H Hsieh; Chun-Houh Chen; Hsuan-Yu Chen; Chun-Chiang Wen; Yung-Hsiang Huang; Po-Chang Hsiao; Chuhsing Kate Hsiao; Chih-Min Liu; Pan-Chyr Yang; Hai-Gwo Hwu; Wei J Chen
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

9.  Integrating microRNA and mRNA expression profiles of neuronal progenitors to identify regulatory networks underlying the onset of cortical neurogenesis.

Authors:  Joseph A Nielsen; Pierre Lau; Dragan Maric; Jeffery L Barker; Lynn D Hudson
Journal:  BMC Neurosci       Date:  2009-08-19       Impact factor: 3.288

10.  Insights on the functional impact of microRNAs present in autism-associated copy number variants.

Authors:  Varadarajan Vaishnavi; Mayakannan Manikandan; Basant K Tiwary; Arasambattu Kannan Munirajan
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  15 in total

1.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

2.  Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.

Authors:  Guoku Hu; Ke Liao; Lu Yang; Gurudutt Pendyala; Yeonhee Kook; Howard S Fox; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-24       Impact factor: 4.147

Review 3.  MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application.

Authors:  Durgesh Tiwari; Katrina Peariso; Christina Gross
Journal:  Dev Dyn       Date:  2017-10-04       Impact factor: 3.780

Review 4.  Role of TSC1 in physiology and diseases.

Authors:  Karthik Mallela; Arun Kumar
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

Review 5.  Genetics of tuberous sclerosis complex: implications for clinical practice.

Authors:  Carolina Caban; Nubaira Khan; Daphne M Hasbani; Peter B Crino
Journal:  Appl Clin Genet       Date:  2016-12-21

Review 6.  New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).

Authors:  Tanjala T Gipson; Michael V Johnston
Journal:  F1000Res       Date:  2017-06-09

7.  Identification of a novel TSC2 c.3610G > A, p.G1204R mutation contribute to aberrant splicing in a patient with classical tuberous sclerosis complex: a case report.

Authors:  Ruixiao Zhang; Jianhong Wang; Qing Wang; Yue Han; Xuejun Liu; Irene Bottillo; Yanhua Lang; Leping Shao
Journal:  BMC Med Genet       Date:  2018-09-20       Impact factor: 2.103

8.  Exosomes in Epilepsy of Tuberous Sclerosis Complex: Carriers of Pro-Inflammatory MicroRNAs.

Authors:  Daniela Cukovic; Shruti Bagla; Dylan Ukasik; Paul M Stemmer; Bhanu P Jena; Akshata R Naik; Sandeep Sood; Eishi Asano; Aimee Luat; Diane C Chugani; Alan A Dombkowski
Journal:  Noncoding RNA       Date:  2021-07-10

Review 9.  miRNAs: biological and clinical determinants in epilepsy.

Authors:  Walid A Alsharafi; Bo Xiao; Mutasem M Abuhamed; Zhaohui Luo
Journal:  Front Mol Neurosci       Date:  2015-10-13       Impact factor: 5.639

10.  Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.

Authors:  James D Mills; Anand M Iyer; Jackelien van Scheppingen; Anika Bongaarts; Jasper J Anink; Bart Janssen; Till S Zimmer; Wim G Spliet; Peter C van Rijen; Floor E Jansen; Martha Feucht; Johannes A Hainfellner; Pavel Krsek; Josef Zamecnik; Katarzyna Kotulska; Sergiusz Jozwiak; Anna Jansen; Lieven Lagae; Paolo Curatolo; David J Kwiatkowski; R Jeroen Pasterkamp; Ketharini Senthilkumar; Lars von Oerthel; Marco F Hoekman; Jan A Gorter; Peter B Crino; Angelika Mühlebner; Brendon P Scicluna; Eleonora Aronica
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.